Classer les publications sur l'année
-
Pharmaco-Epidémiologie
DĂ©lais Ă©volutifs des syndromes Ă©pileptiques avant leur diagnostic : rĂ©sultats descriptifs de l’enquĂȘte CAROLE
Groupe CAROLE
Revue de Neurologie ; 2000;156; (5) : 481-490
-
Pharmaco-Epidémiologie
ESPERA study : Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice
DE TOFFOL B, DE ZELICOURT M, VESPIGNANI H, FAGNANI F, LAURENDEAU C, LEVY-BACHELOT L, MURAT C, GASALLA T, ARZIMANOGLOU A, VILLANUEVA V
Epilepsy Behav ; 2012;25(2):166-169
-
Ăconomie de la santĂ©
Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study
VILLANUEVA V, GIRĂN JM, MARTĂN J, HERNĂNDEZ-PASTOR LJ, LAHUERTA J, DOZ M, CUESTA M, LĂVY-BACHELOT L; INVESTIGADORES DEL ESTUDIO ESPERA
Neurologia ; 2013;28(4):195-204
-
Ăconomie de la santĂ©
IntĂ©rĂȘt des bases de remboursement de lâAssurance maladie pour lâanalyse de la prise en charge des maladies chroniques : le cas de lâĂ©pilepsie
FAGNANI F, VESPIGNANI H, KUSNIK-JOINVILLE O, BERTRAND M, MURAT C, LEVY-BACHELOT L, KAHANE P
Presse Med ; 2013;42:285-292
-
Pharmaco-Epidémiologie
Management of focal epilepsy in adults treated with polytherapy in France : The direct cost of drug resistance (ESPERA study)
DE ZĂLICOURT M, DE TOFFOL B, VESPIGNANI H, LAURENDEAU C, LĂVY-BACHELOT L, MURAT C, FAGNANI F
Seizure ; 2014;23(5):349-356
-
Pharmaco-Epidémiologie
[Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: Description according to the 2009 ILAE definition of AED resistance (ESPERA study)]
VESPIGNANI H, DE ZĂLICOURT M, LAURENDEAU C, FAGNANI F, LEVY-BACHELOT L, MURAT C, KAHANE P, DE TOFFOL B
Rev Neurol ; 2014;170(2): 100-109